Vericel (VCEL) Profit After Tax Growth (1y) (2011 - 2026)
Vericel (VCEL) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 0.26% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -107.76% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 101.22% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Vericel | 2.33 Bn | 2.18 Bn | 49.27 Mn | 43.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.96% |
| Dec 31, 2025 | 17.26% |
| Sep 30, 2025 | 663.15% |
| Jun 30, 2025 | 88.19% |
| Mar 31, 2025 | -191.20% |
| Dec 31, 2024 | 52.44% |
| Sep 30, 2024 | 75.38% |
| Jun 30, 2024 | 6.73% |
| Mar 31, 2024 | 48.47% |
| Dec 31, 2023 | 119.40% |
| Sep 30, 2023 | 44.35% |
| Jun 30, 2023 | 43.99% |
| Mar 31, 2023 | -5.70% |
| Dec 31, 2022 | 30.58% |
| Sep 30, 2022 | -33.38% |
| Jun 30, 2022 | -136.74% |
| Mar 31, 2022 | -115.60% |
| Dec 31, 2021 | -62.89% |
| Sep 30, 2021 | -236.29% |
| Jun 30, 2021 | 54.21% |